Peruzzi W T, Shapiro B A, Noskin G A, Currie D L, Skoutelis A, Murphy R L, Cane R D, Blake M J
Department of Anesthesia, Northwestern Memorial Hospital, Chicago, Ill 60611.
Chest. 1992 May;101(5):1399-403. doi: 10.1378/chest.101.5.1399.
To determine and compare the incidence of concurrent bacterial lung infection in intubated and nonintubated patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii pneumonia (PCP) requiring medical intensive care unit (MICU) admission for support of their respiratory function.
Retrospective review of medical records.
A large university hospital and AIDS treatment center.
All AIDS/PCP patients admitted to the MICU for support of oxygenation and/or ventilation between 1985 and 1989. Survival was defined as discharge from the hospital; nonsurvival was defined as death any time during the hospitalization. Patients with acute spinal cord injury (SCI) were used as controls to determine the incidence of nosocomial pneumonia in ICU patients of similar age without AIDS.
Twenty-nine AIDS/PCP patients met study criteria; eight (28 percent) were survivors and 21 (72 percent) were nonsurvivors. There was no significant difference in duration of intubation or duration of ICU stay between survivors and nonsurvivors with or without intubation. The incidence of bacterial concurrent lung infection (CLI) in AIDS/PCP patients overall was 7 percent and in intubated AIDS/PCP patients it was 10 percent. There was no statistically significant difference in the incidence of bacterial CLI between the survivors and nonsurvivors or between intubated and nonintubated patients with AIDS/PCP. The incidence of nosocomial pneumonia in SCI overall was 17 percent and in intubated SCI patients it was 30 percent.
The incidence of bacterial lung infections in our retrospective study of AIDS patients with PCP is remarkably less than in the general ICU population with respiratory failure and in our control patients with SCI, although the differences did not attain statistical significance. This finding may be related to antimicrobial therapy directed against P carinii. Endotracheal intubation in patients with AIDS and PCP, who were undergoing appropriate antimicrobial therapy, did not result in a significantly higher incidence of bacterial lung infections than in those who were not intubated. There was no significant difference in the incidence of bacterial lung infections between those AIDS/PCP patients who survived episodes of severe respiratory failure and those who did not. Endotracheal intubation should not be delayed or withheld from this patient population due to concerns of pulmonary bacterial superinfection.
确定并比较因获得性免疫缺陷综合征(AIDS)和卡氏肺孢子虫肺炎(PCP)而需要入住医学重症监护病房(MICU)以支持呼吸功能的插管患者和非插管患者并发细菌性肺部感染的发生率。
对病历进行回顾性研究。
一家大型大学医院及艾滋病治疗中心。
1985年至1989年间因支持氧合和/或通气而入住MICU的所有艾滋病/PCP患者。生存定义为出院;非生存定义为住院期间任何时间死亡。急性脊髓损伤(SCI)患者作为对照,以确定无艾滋病的相似年龄ICU患者的医院获得性肺炎发生率。
29例艾滋病/PCP患者符合研究标准;8例(28%)存活,21例(72%)未存活。存活者与未存活者(无论是否插管)之间的插管持续时间或ICU住院时间无显著差异。艾滋病/PCP患者总体细菌性并发肺部感染(CLI)发生率为7%,插管的艾滋病/PCP患者为10%。存活者与未存活者之间或插管与未插管的艾滋病/PCP患者之间细菌性CLI发生率无统计学显著差异。SCI患者总体医院获得性肺炎发生率为17%,插管的SCI患者为30%。
在我们对患有PCP的艾滋病患者的回顾性研究中,细菌性肺部感染的发生率显著低于呼吸衰竭的普通ICU患者和我们的SCI对照患者,尽管差异未达到统计学显著性。这一发现可能与针对卡氏肺孢子虫的抗菌治疗有关。接受适当抗菌治疗的艾滋病和PCP患者进行气管插管,其细菌性肺部感染发生率并不比未插管患者显著更高。在经历严重呼吸衰竭发作后存活的艾滋病/PCP患者与未存活患者之间,细菌性肺部感染发生率无显著差异。不应因担心肺部细菌重叠感染而延迟或不给该患者群体进行气管插管。